EMA To Become Observer Of FDA’s Project Orbis Early This Year

The European medicines regulator has put in place the necessary arrangements to begin watching the Project Orbis process imminently but has maintained its stance that the initiative focuses only on the “magic moment” of a drug approval.

US and EU collaboration
• Source: Shutterstock

The Project Orbis initiative, an international regulatory collaboration led by the US Food and Drug Administration, could soon welcome the European Medicines Agency as an observer.

The EMA’s intention to watch the Orbis process more closely was announced in June 2023, but little was revealed about...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet